Interleukin-7 and Vaccine Therapy in Treating Patients With Metastatic Melanoma

NCT00091338 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

NIH

Sponsor class

Conditions

Melanoma (Skin)

Interventions

BIOLOGICAL: MART-1 antigen
BIOLOGICAL: gp100 antigen
BIOLOGICAL: incomplete Freund's adjuvant
BIOLOGICAL: recombinant interleukin-7

Sponsor

National Cancer Institute (NCI)